RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ZITELLA A
Collezione AOU Città della Salute di Torino

Items : 9

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer. in JAMA network open / JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039.

2023
ASL Cuneo 2
ASL Asti
AOU Alessandria
AO Cuneo
ASL Alessandria
ASL Torino 3
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
ASL Biella

Bollito E; Gontero P; Porpiglia F; Galassi C; Bertetto O; Zitella A; Zaramella S; Zarrelli G; Stancati S; Surleti D; Varvello F; Volpe A; Squeo MS; Ponti di Sant'Angelo F; Ruggiero L; Ruo Redda MG; Serao A; Muto G; Migliari R; Molinaro L; Montefiore F; Moroni M; Montefusco G; Guercio S; Garibaldi E; Girelli G; Griffa D; Dalmasso E; Di Stasio A; et alii...

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk. in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology / Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1769-1779. doi: 10.1158/1055-9965.EPI-22-0123.

2022
AOU Città della Salute di Torino

Grasso C; Popovic M; Isaevska E; Lazzarato F; Fiano V; Zugna D; Pluta J; Weathers B; D'Andrea K; Almstrup K; Anson-Cartwright L; Bishop DT; Chanock SJ; Chen C; Cortessis VK; Dalgaard MD; Daneshmand S; Ferlin A; Foresta C; Frone MN; Gamulin M; Gietema JA; Greene MH; Grotmol T; Hamilton RJ; Haugen TB; Hauser R; Karlsson R; Kiemeney LA; et alii...

Ki-67, topoisomerase II? and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort. in Translational andrology and urology / Transl Androl Urol. 2022 Sep;11(9):1271-1281. doi: 10.21037/tau-21-628.

2022
AOU Città della Salute di Torino

Marra G; Oderda M; Calleris G; Marquis A; Peretti F; Zitella A; Moschini M; Sanchez-Salas R; Karnes RJ; Kneitz B; Spahn M; Pacchioni D; Gontero P;

Low Levels of Urinary PSA Better Identify Prostate Cancer Patients. in Cancers / Cancers (Basel). 2021 Jul 16;13(14):3570. doi: 10.3390/cancers13143570.

2021
AOU Città della Salute di Torino

Occhipinti S; Mengozzi G; Oderda M; Zitella A; Molinaro L; Novelli F; Giovarelli M; Gontero P;

(68)Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Ap

2020
AOU Città della Salute di Torino

Parise R; Carlevato R; Bellò M; Zitella A; Passera R; Pilati E; Nicolotti DG; Oderda M; Bartoncini S; Lillaz B; Ceci F; Guarneri A; Deandreis D; Ricardi U; Gontero P;

Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study. in Urology / Urology. 2020 Jun;140:122-131. doi: 10.1016/j.urology.2019.11.078. Epub 2020 Feb 13.

2020
AOU Città della Salute di Torino

Bergamasco L; Zitella A; Molinaro L; Faletti R; Falcone M; Calleris G; Oderda M; D'Agate D; Tappero S; Marquis A; Marra G; Gontero P;

New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies. in International archives of occupational and environmental health / Int Arch Occup Environ Health. 2019 Apr;92(3):347-359. doi: 10.1007/s00420-018-1388-2. Epub 2018 Nov

2019
AOU Città della Salute di Torino

Vineis P; Cucchiarale G; Casetta G; Zitella A; Gontero P; Rolle L; Destefanis P; Carnà P; Maule M; Arici C; Fasanelli F; Giraudo MT; d'Errico A; Carta A; Sciannameo V; Porru S; Sacerdote C; Ricceri F; Sciannameo V; Carta A; d'Errico A; Giraudo MT; Fasanelli F; Arici C; Maule M; Carnà P; Destefanis P; Rolle L; Gontero P; et alii...

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? in The Prostate / Prostate. 2015 Aug 1;75(11):1177-86. doi: 10.1002/pros.22999. Epub 2015 Apr 20.

2015
AOU Città della Salute di Torino

Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P;

Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer. in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology / Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2439-46. doi: 10.1158/1055-9965.EPI-14-0228. Epub

2014
AOU Città della Salute di Torino

Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G;